News

Dr. Reddy's Laboratories slides Friday, outperforms competitors
Dr. Reddy's Laboratories Ltd. closed 17.37% short of its 52-week high of 1,420.20 rupees, which the company achieved on ...
Dr. Reddy’s Looks Well Positioned for Long-Term Growth, Aided by Acquisitions and Partnerships
Besides generics, Dr. Reddy’s has committed a lot of resources to develop its biosimilars as well as new chemical entity business. Biosimilars have been seen as a growth engine for large, capable ...
ET Now on MSN5d
Stocks To Watch Today, April 23: Gensol, PFC, HCL Tech, IOC, ITC Hotels, Havells, Tata Communications and more
Top stocks to watch out for today include Gensol Engineering, PFC, HCL Tech, ITC Hotels, Indian Oil, Tata Communications, Havells India, Hathway Cable, IndusInd Bank, AU Small Finance Bank and Airtel ...
Dr Reddy's, Lupin recall products in US due to labelling, manufacturing errors: USFDA
Dr. Reddy's Laboratories and Lupin are recalling products in the US due to labeling and manufacturing issues. Dr. Reddy's is ...
Rediff Money6d
Dr Reddy's, Lupin Recall Drugs in US Due to Errors
Dr Reddy's and Lupin are recalling drugs in the US due to labelling and manufacturing errors, respectively, according to the ...